43 results
S-1
EX-10.10
OCGN
Ocugen Inc
7 Oct 14
IPO registration
12:00am
of manufacturing. Angiotech shall be responsible for costs associated with the termination by Angiotech of the manufacture, storage and packaging of CT3 … designations, provided however, that all packaging of CT3 included in the Eligible Products shall be marked with the trademark “****TM” (in a form
DRS/A
EX-10
OCGN
Ocugen Inc
6 Oct 14
Draft registration statement (amended)
12:00am
, packaging, and labeling for Collaboration Products, as provided under and in accordance with Section 4.8.
3.2 Sublicensing. Except as provided … Products and to the extent permitted by applicable law and regulations, Histogenics shall ensure that the packaging, promotional materials
S-1
EX-10.35
syu qmlz4zg
7 Oct 14
IPO registration
12:00am
8-K
EX-10.1
1rutsg42kjbv
10 Jun 22
Entry into a Material Definitive Agreement
4:37pm
8-K
EX-10.1
nk87x5mmm525k62 yjxl
14 Aug 20
Entry into a Material Definitive Agreement
9:07pm
8-K
EX-10.1
1gx f6vre55
8 May 20
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
8diwh1k
12 Jun 20
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-1.1
xq83fnb enaq80
25 Feb 22
Entry into a Material Definitive Agreement
7:30am
8-K
EX-1.1
kisc6wg7
25 May 23
Entry into a Material Definitive Agreement
5:02pm
424B3
wbwhwm
6 Nov 19
Prospectus supplement
8:55am